company background image
950 logo

Lee's Pharmaceutical Holdings SEHK:950 Voorraadrapport

Laatste prijs

HK$1.25

Marktkapitalisatie

HK$736.0m

7D

1.6%

1Y

2.5%

Bijgewerkt

04 Nov, 2024

Gegevens

Financiële gegevens bedrijf

Lee's Pharmaceutical Holdings Limited

SEHK:950 Voorraadrapport

Marktkapitalisatie: HK$736.0m

950 Overzicht aandelen

Lee's Pharmaceutical Holdings Limited, een investeringsholding, ontwikkelt, produceert, verkoopt en verhandelt farmaceutische producten voornamelijk in de Volksrepubliek China.

Lee's Pharmaceutical Holdings Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Lee's Pharmaceutical Holdings
Historische aandelenkoersen
Huidige aandelenkoersHK$1.25
52 Week HoogtepuntHK$1.75
52 Week LaagHK$1.00
Bèta0.86
11 maand verandering-12.59%
3 maanden verandering1.63%
1 Jaar Verandering2.46%
33 jaar verandering-64.49%
5 jaar verandering-72.22%
Verandering sinds IPO140.38%

Recent nieuws en updates

Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

Sep 04
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

Recent updates

Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

Sep 04
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Aug 07
There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

May 21
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Dec 20
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Apr 02
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Aug 29
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Apr 05
Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Mar 17
Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

Feb 22
Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 29
What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Jan 12
What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Rendement voor aandeelhouders

950HK PharmaceuticalsHK Markt
7D1.6%-7.2%-1.0%
1Y2.5%-2.9%15.0%

Rendement versus industrie: 950 exceeded the Hong Kong Pharmaceuticals industry which returned -2.9% over the past year.

Rendement versus markt: 950 underperformed the Hong Kong Market which returned 15% over the past year.

Prijsvolatiliteit

Is 950's price volatile compared to industry and market?
950 volatility
950 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement9.0%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.3%

Stabiele aandelenkoers: 950 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatiliteit in de loop van de tijd: 950's weekly volatility (7%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1994993n/awww.leespharm.com

Lee's Pharmaceutical Holdings Limited, een investeringsholding, ontwikkelt, produceert, verkoopt en verhandelt farmaceutische producten voornamelijk in de Volksrepubliek China. Het bedrijf richt zich op verschillende ziektegebieden, waaronder hart- en vaatziekten, vrouwengeneeskunde, kindergeneeskunde, zeldzame ziekten, oncologie, dermatologie en verloskunde. Het bedrijf is actief in de segmenten Eigen en Generieke Producten en Licentieproducten.

Lee's Pharmaceutical Holdings Limited Samenvatting

Hoe verhouden de winst en inkomsten van Lee's Pharmaceutical Holdings zich tot de beurswaarde?
950 fundamentele statistieken
MarktkapitalisatieHK$736.04m
Inkomsten(TTM)HK$63.06m
Inkomsten(TTM)HK$1.20b

11.7x

Koers/Winstverhouding

0.6x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
950 resultatenrekening (TTM)
InkomstenHK$1.20b
Kosten van inkomstenHK$581.63m
BrutowinstHK$617.44m
Overige uitgavenHK$554.38m
InkomstenHK$63.06m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.11
Brutomarge51.49%
Nettowinstmarge5.26%
Schuld/Eigen Vermogen Verhouding14.2%

Hoe presteerde 950 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.4%

Huidig dividendrendement

28%

Uitbetalingsratio